Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation
Open Access
- 1 November 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 14 (11) , 2634-2638
- https://doi.org/10.1093/ndt/14.11.2634
Abstract
Background. Cyclosporin (CsA)-induced vascular dysfunction has been attributed to a diminished role of the nitric oxide (NO)/cGMP-mediated vasodilator mechanism. The present study was aimed at investigating whether l-arginine, the substrate of NO synthesis, ameliorates CsA-induced vascular dysfunction. Methods. Male Sprague–Dawley rats were used throughout the study. The thoracic aorta was isolated from normal rats and acutely treated with CsA (10−4 mol/l, 60 min) in vitro, or the aorta was taken from rats treated with CsA (25 mg/kg/day, i.m., 1 week). The vascular relaxation response to acetylcholine, and tissue levels of NO metabolites and cGMP were determined. The vascular expression of NO synthase (NOS) isoforms was also determined by western blot analysis. Results. Acute treatment with CsA in vitro markedly attenuated the vasorelaxation response to acetylcholine, which was completely restored by l-arginine. The vascular accumulation of NO metabolites in response to acetylcholine was decreased significantly by CsA, which was prevented by cotreatment with l-arginine. CsA decreased the cGMP accumulation in response to both acetylcholine and sodium nitroprusside. l-Arginine restored, although not completely, acetylcholine-stimulated cGMP generation, whereas it did not affect sodium nitroprusside-stimulated cGMP generation. Following chronic CsA treatment in the whole animal, the vasorelaxation response to acetylcholine was decreased significantly along with tissue levels of NO metabolites; this was preserved by l-arginine-supplementation. Vascular expression of iNOS protein was decreased by CsA treatment along with decreased tissue accumulation of NO metabolites. l-arginine supplementation did not modify the altered expression of NOS proteins. Conclusion. These results suggest that CsA causes an l-arginine-sensitive vascular dysfunction which is associated with impaired generation of NO and cGMP.Keywords
This publication has 12 references indexed in Scilit:
- Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertensionKidney International, 1998
- Measurement of nitrite and nitrate levels in plasma and urine — what does this measure tell us about the activity of the endogenous nitric oxite system?Current Opinion in Nephrology and Hypertension, 1998
- Influence of Dietary Sodium Intake on Renal Medullary Nitric Oxide SynthaseHypertension, 1996
- A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginineKidney International, 1995
- Cyclosporin A Inhibits Nitric Oxide Synthase Induction in Vascular Smooth Muscle CellsHypertension, 1995
- SUPPRESSION OF NITRIC OXIDE PRODUCTION BY CYCLOSPORIN A AND FK506A IN RAT VASCULAR SMOOTH MUSCLE CELLSClinical and Experimental Pharmacology and Physiology, 1994
- THE EFFECTS OF CYCLOSPORIEN ON VASCULAR RESPONSIVENESS AND RENIN RELEASE FROM THE KIDNEYTransplantation, 1992
- HYPERTENSION AFTER RENAL TRANSPLANTATIONTransplantation, 1987
- Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin-aldosterone systemThe American Journal of Cardiology, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976